In the United States, it costs more to maintain MS $ 85 billion

By Robert Preidt HealthDay Reporter
Health Announcer

THURSDAY, April 14, 2022 (HealthDay News) – In 2019 alone, multiple sclerosis (MS) cost Americans $ 85.4 billion, new research shows.

That money was invested in over $ 63 billion in direct medical costs and $ 22 billion in nonprofit costs.

“The findings of this study help to demonstrate the prevalence of MS in the U.S. and we hope that our results will inform decision -making about MS -related health resources,” the research author said. Bruce Bebo. He is the executive vice president for research at the National Multiple Sclerosis Society.

MS is an undiagnosed disease of the central nervous system, in which the human immune system attacks the brain and spinal cord. Symptoms can include numbness, tingling, mood swings, memory problems, pain, fatigue, blindness and dizziness, depending on the group.

At nearly $ 38 billion, prescription drugs accounted for the largest share (54%) of direct health costs. This was followed by office -administered medications at $ 6.7 billion (12%), and outpatient care at $ 5.5 billion (9%), the researchers reported.

Compared to someone without MS, MS patients cost more than $ 65,000 in health care costs. That with $ 35,000 for medicine, the grant is known.

The annual cost for a person taking MS medications ranges from $ 57,000 to nearly $ 93,000, according to a report published online April 13 in the journal. Nūnū.

But medicine and health care are not the only factors that contribute to the economic growth of MS. People with neurologic disease may limit their activity and may not be able to work, reducing their productivity and income.

The families of the patients may have to give up their jobs to work as caregivers, the authors said.

“Multiple sclerosis is a serious disease to treat and the debilitating effects of MS can result in significant disruption to daily life including exercise, physical independence, mobility and social interaction. “Bebo said in a news release.

For the study, researchers evaluated Medicare and insurance claims from fewer than 10,600 people with MS and nearly 106,000 others. They also researched about 950 participants and their clients about independent costs, such as loss of performance or loss of product in production, the cost of products. unpaid care, and home changes.

“Right now, in the U.S., there are about one million parents with MS and we estimate that by 2039, there will be about 1.2 million people living with MS,” Bebo said. “With this, the real estate market will increase to $ 108.1 billion.”

See more

The National Multiple Sclerosis Society has more to say about MS.

KUMU: Nūnūnews release, April 13, 2022

Related Posts

Leave a Reply

Your email address will not be published.